|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
57,080,000 |
Market
Cap: |
151.26(M) |
Last
Volume: |
97,895 |
Avg
Vol: |
96,979 |
52
Week Range: |
$1.6 - $4.2 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 4.7 |
Insider 6 Months : 7.7 |
Insider 3/6 Months : 12.5 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
3,900 |
10,900 |
11,800 |
30,698 |
Total Buy Value |
$9,006 |
$29,316 |
$31,165 |
$57,953 |
Total People Bought |
2 |
4 |
4 |
5 |
Total Buy Transactions |
4 |
8 |
10 |
16 |
Total Shares Sold |
0 |
25,000 |
25,000 |
25,000 |
Total Sell Value |
$0 |
$76,500 |
$76,500 |
$76,500 |
Total People Sold |
0 |
1 |
1 |
1 |
Total Sell Transactions |
0 |
2 |
2 |
2 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
10x Capital Management, Llc |
10% Owner |
|
2018-06-14 |
4 |
AS |
$7.99 |
$632,133 |
I/I |
(76,385) |
2,725,261 |
|
- |
|
Czirr James C |
Director |
|
2018-06-14 |
4 |
AS |
$7.99 |
$632,133 |
I/I |
(76,385) |
2,725,261 |
|
- |
|
Traber Peter G |
President & CEO |
|
2018-06-13 |
4 |
AS |
$7.51 |
$751,000 |
D/D |
(100,000) |
107,333 |
|
- |
|
Traber Peter G |
President & CEO |
|
2018-06-13 |
4 |
OE |
$0.87 |
$87,000 |
D/D |
100,000 |
207,333 |
|
- |
|
Shlevin Harold H. |
Chief Operating Officer |
|
2018-06-13 |
4 |
AS |
$7.79 |
$240,916 |
D/D |
(30,918) |
0 |
|
- |
|
Shlevin Harold H. |
Chief Operating Officer |
|
2018-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,544 |
30,918 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2018-06-13 |
4 |
AS |
$6.59 |
$1,493,276 |
I/I |
(208,140) |
2,801,646 |
|
- |
|
Czirr James C |
Director |
|
2018-06-13 |
4 |
AS |
$6.59 |
$1,493,276 |
I/I |
(208,140) |
2,801,646 |
|
- |
|
Callicutt Jack W |
Chief Financial Officer |
|
2018-06-12 |
4 |
AS |
$7.01 |
$65,167 |
D/D |
(9,294) |
1,260 |
|
- |
|
Callicutt Jack W |
Chief Financial Officer |
|
2018-06-12 |
4 |
OE |
$1.37 |
$12,733 |
D/D |
9,294 |
10,554 |
|
- |
|
Shlevin Harold H. |
Chief Operating Officer |
|
2018-06-12 |
4 |
AS |
$6.50 |
$83,070 |
D/D |
(12,780) |
5,374 |
|
- |
|
Shlevin Harold H. |
Chief Operating Officer |
|
2018-06-11 |
4 |
AS |
$6.50 |
$69,940 |
D/D |
(10,760) |
18,154 |
|
- |
|
Callicutt Jack W |
Chief Financial Officer |
|
2018-06-11 |
4 |
AS |
$6.38 |
$127,500 |
D/D |
(20,000) |
1,260 |
|
- |
|
Callicutt Jack W |
Chief Financial Officer |
|
2018-06-11 |
4 |
OE |
$1.37 |
$27,400 |
D/D |
20,000 |
21,260 |
|
- |
|
Shlevin Harold H. |
Chief Operating Officer |
|
2018-06-08 |
4 |
AS |
$5.77 |
$602,048 |
D/D |
(104,294) |
28,914 |
|
- |
|
Shlevin Harold H. |
Chief Operating Officer |
|
2018-06-08 |
4 |
OE |
$0.87 |
$83,633 |
D/D |
79,294 |
184,099 |
|
- |
|
Callicutt Jack W |
Chief Financial Officer |
|
2018-06-08 |
4 |
AS |
$5.75 |
$575,000 |
D/D |
(100,000) |
1,260 |
|
- |
|
Callicutt Jack W |
Chief Financial Officer |
|
2018-06-08 |
4 |
OE |
$0.87 |
$87,000 |
D/D |
100,000 |
101,260 |
|
- |
|
10x Capital Management, Llc |
10% Owner |
|
2018-06-08 |
4 |
AS |
$5.64 |
$646,800 |
I/I |
(110,000) |
3,009,786 |
|
- |
|
Traber Peter G |
President & CEO |
|
2018-06-08 |
4 |
AS |
$5.86 |
$409,997 |
D/D |
(70,000) |
107,333 |
|
- |
|
Traber Peter G |
President & CEO |
|
2018-06-08 |
4 |
OE |
$0.87 |
$60,900 |
D/D |
70,000 |
177,333 |
|
- |
|
Czirr James C |
Director |
|
2018-06-08 |
4 |
AS |
$5.64 |
$646,800 |
I/I |
(110,000) |
3,009,786 |
|
- |
|
Shlevin Harold H. |
Chief Operating Officer |
|
2018-06-07 |
4 |
AS |
$5.21 |
$525,269 |
D/D |
(100,891) |
53,914 |
|
- |
|
Shlevin Harold H. |
Chief Operating Officer |
|
2018-06-07 |
4 |
OE |
$0.87 |
$196,801 |
D/D |
100,891 |
154,805 |
|
- |
|
Shlevin Harold H. |
Chief Operating Officer |
|
2018-06-06 |
4 |
AS |
$5.15 |
$46,752 |
D/D |
(9,078) |
53,914 |
|
- |
|
320 Records found
|
|
Page 9 of 13 |
|
|